Equity Investing
Why ARCA biopharma, Inc. (ABIO) stock is rising high in aftermarket?
ARCA biopharma, Inc. (ABIO) experiences an incline of 9.92% in the aftermarket because the company updated about the ASPEN-COVID-19 Phase 2b clinical study. However, the